541 related articles for article (PubMed ID: 38426096)
1. When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms.
Zhao XC; Ju B; Xiu NN; Sun XY; Meng FJ
Front Immunol; 2024; 15():1339971. PubMed ID: 38426096
[TBL] [Abstract][Full Text] [Related]
2. Leukemic transformation during anti-tuberculosis treatment in aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome: A case report and review of literature.
Xiu NN; Yang XD; Xu J; Ju B; Sun XY; Zhao XC
World J Clin Cases; 2023 Oct; 11(28):6908-6919. PubMed ID: 37901004
[TBL] [Abstract][Full Text] [Related]
3. Flared inflammatory episode transforms advanced myelodysplastic syndrome into aplastic pancytopenia: A case report and literature review.
Ju B; Xiu NN; Xu J; Yang XD; Sun XY; Zhao XC
World J Clin Cases; 2023 Jun; 11(17):4105-4116. PubMed ID: 37388797
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis-induced aplastic crisis and atypical lymphocyte expansion in advanced myelodysplastic syndrome: A case report and review of literature.
Sun XY; Yang XD; Xu J; Xiu NN; Ju B; Zhao XC
World J Clin Cases; 2023 Jul; 11(19):4713-4722. PubMed ID: 37469724
[TBL] [Abstract][Full Text] [Related]
5. Malignant progression of preleukemic disorders.
Hall T; Gurbuxani S; Crispino JD
Blood; 2024 May; 143(22):2245-2255. PubMed ID: 38498034
[TBL] [Abstract][Full Text] [Related]
6. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
7. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
8. Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation.
Drexler B; Zurbriggen F; Diesch T; Viollier R; Halter JP; Heim D; Holbro A; Infanti L; Buser A; Gerull S; Medinger M; Tichelli A; Passweg JR
Ann Hematol; 2020 Nov; 99(11):2529-2538. PubMed ID: 32948913
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune pathogenesis, immunosuppressive therapy and pharmacological mechanism in aplastic anemia.
Pan P; Chen C; Hong J; Gu Y
Int Immunopharmacol; 2023 Apr; 117():110036. PubMed ID: 36940553
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of aplastic anemia with cytogenetic abnormalities at diagnosis.
Li J; Liu X; Zhao X; Yang W; Zhang L; Jing L; Zhou K; Ye L; Li Y; Li Y; Peng G; Song L; Fan H; Hu X; Li X; Zhang F
Eur J Haematol; 2023 Apr; 110(4):379-385. PubMed ID: 36533899
[TBL] [Abstract][Full Text] [Related]
11. Acquired aplastic anemia associated with trisomy eight converting into acute myeloid leukemia.
Grover S; Dhiman AK; Garg B; Sood N; Narang V
J Lab Physicians; 2017; 9(3):207-209. PubMed ID: 28706392
[TBL] [Abstract][Full Text] [Related]
12. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
[TBL] [Abstract][Full Text] [Related]
13. Treatment responses of childhood aplastic anaemia with chromosomal aberrations at diagnosis.
Ohga S; Ohara A; Hibi S; Kojima S; Bessho F; Tsuchiya S; Ohshima Y; Yoshida N; Kashii Y; Nishimura S; Kawakami K; Nishikawa K; Tsukimoto I;
Br J Haematol; 2002 Jul; 118(1):313-9. PubMed ID: 12100167
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow free immune checkpoints as a potential biomarker for differential diagnosis of acquired bone marrow failures.
Zang M; Li N; Chen Q; Ran N; Fu R; Shao Z; Wang T
J Clin Lab Anal; 2022 Oct; 36(10):e24677. PubMed ID: 36086857
[TBL] [Abstract][Full Text] [Related]
15. Relapse and transformation to myelodysplastic syndrome and acute myeloid leukemia following immunosuppressive therapy for aplastic anemia is more common as compared to allogeneic stem cell transplantation with a negative impact on survival.
Chattopadhyay S; Lionel S; Selvarajan S; Devasia AJ; Korula A; Kulkarni U; Aboobacker FN; Lakshmi KM; Srivastava A; Mathews V; Abraham A; George B
Ann Hematol; 2024 Mar; 103(3):749-758. PubMed ID: 38242970
[TBL] [Abstract][Full Text] [Related]
16. Hypoplastic myelodysplastic syndrome and acquired aplastic anemia: Immune‑mediated bone marrow failure syndromes (Review).
Votavova H; Belickova M
Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34958107
[TBL] [Abstract][Full Text] [Related]
17. Association between human leukocyte antigen and immunosuppressive treatment outcomes in Chinese patients with aplastic anemia.
Chen L; Ge M; Huo J; Ren X; Shao Y; Li X; Huang J; Wang M; Nie N; Zhang J; Peng J; Zheng Y
Front Immunol; 2023; 14():1056381. PubMed ID: 36793734
[TBL] [Abstract][Full Text] [Related]
18. Leukemia cells impair normal hematopoiesis and induce functionally loss of hematopoietic stem cells through immune cells and inflammation.
Cui P; Zhang Y; Cui M; Li Z; Ma G; Wang R; Wang N; Huang S; Gao J
Leuk Res; 2018 Feb; 65():49-54. PubMed ID: 29306107
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis on malignant clonal hematopoiesis in severe aplastic anemia patients with immunosuppressive therapy].
Cui N; Fu R; Qu W; Ruan E; Wang X; Wang G; Wu Y; Liu H; Guan J; Song J; Xing L; Li L; Jiang H; Liu H; Wang Y; Liu C; Zhang W; Wang H; Shao Z
Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(32):2620-2. PubMed ID: 26711612
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes.
Matsui WH; Brodsky RA; Smith BD; Borowitz MJ; Jones RJ
Leukemia; 2006 Mar; 20(3):458-62. PubMed ID: 16437138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
